Cargando…
Novel Therapies in APOL1-Mediated Kidney Disease: From Molecular Pathways to Therapeutic Options
Apolipoprotein L1 (APOL1) high-risk variants confer an increased risk for the development and progression of kidney disease among individuals of recent African ancestry. Over the past several years, significant progress has been made in understanding the pathogenesis of APOL1-mediated kidney disease...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658239/ https://www.ncbi.nlm.nih.gov/pubmed/38025220 http://dx.doi.org/10.1016/j.ekir.2023.08.028 |